120 related articles for article (PubMed ID: 6209008)
1. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
[No Abstract] [Full Text] [Related]
2. A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients.
Gentile PS; Epremian BE; Seeger J; Hamm JT; Sheth SP
Am J Clin Oncol; 1988 Dec; 11(6):666-8. PubMed ID: 2461074
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.
Johnson DH; Presant C; Einhorn L; Bartolucci AA; Greco FA
Cancer Treat Rep; 1985; 69(7-8):821-4. PubMed ID: 2410120
[TBL] [Abstract][Full Text] [Related]
4. Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.
Oratz R; Speyer JL; Green M; Blum R; Wernz JC; Muggia FM
Cancer Treat Rep; 1987 Sep; 71(9):877-8. PubMed ID: 3621224
[No Abstract] [Full Text] [Related]
5. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
[No Abstract] [Full Text] [Related]
7. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
Cohen SM; Ohnuma T; Ambinder EP; Holland JF
Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
[No Abstract] [Full Text] [Related]
8. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Serrone L; Zeuli M; Sega FM; Cognetti F
J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
[No Abstract] [Full Text] [Related]
10. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
Del Prete SA; Maurer LH; O'Donnell J; Forcier RJ; LeMarbre P
Cancer Treat Rep; 1984 Nov; 68(11):1403-5. PubMed ID: 6541973
[No Abstract] [Full Text] [Related]
11. Treatment of metastatic malignant melanoma with vinblastine, dacarbazine, and cisplatin: a report from the Cancer and Leukemia Group B.
Carey RW; Anderson JR; Green M; Ellison RR; Nathanson L; Kennedy BJ
Cancer Treat Rep; 1986 Mar; 70(3):329-31. PubMed ID: 2420443
[No Abstract] [Full Text] [Related]
12. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
Pyrhönen S; Hahka-Kemppinen M; Muhonen T; Nikkanen V; Eskelin S; Summanen P; Tarkkanen A; Kivelä T
Cancer; 2002 Dec; 95(11):2366-72. PubMed ID: 12436444
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of malignant melanoma].
Ishihara K; Yamazaki N; Asano K
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma.
Cohen SM; Ohnuma T; Cheung T; Holland JF
Cancer Treat Rep; 1983 Oct; 67(10):947-8. PubMed ID: 6194881
[No Abstract] [Full Text] [Related]
15. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.
Nathanson L; Wittenberg BK
Cancer Treat Rep; 1980 Jan; 64(1):133-7. PubMed ID: 6155208
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
Luikart SD; Kennealey GT; Kirkwood JM
J Clin Oncol; 1984 Mar; 2(3):164-8. PubMed ID: 6199481
[TBL] [Abstract][Full Text] [Related]
17. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
18. [Chemotherapy of malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
[TBL] [Abstract][Full Text] [Related]
19. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B
Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
[TBL] [Abstract][Full Text] [Related]
20. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
Nuzzo C; Zeuli M; Ferraresi V; Ciccarese M; Pelligrini D; Cognetti F
Anticancer Res; 2008; 28(2B):1429-31. PubMed ID: 18505091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]